-

05:38:02 AM

EW Stock News

EW - Edwards Lifesciences Corp

05/23/22 8:10 AM

NYSE : EW

conferences

EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE

Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernstein 38th Annual Strategic Decisions Conference on Thursday, June 2, 2022.Michael A. Mussallem, chairman and chief executive officer, is scheduled to

RHEA-AI

neutral

05/16/22 9:15 AM

NYSE : EW

EDWARDS ANNOUNCES KEY EVENTS FOR EUROPCR 2022

Edwards Lifesciences Corporation (NYSE: EW) announced key events for the company during EuroPCR 2022, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). The event takes place May 17 to 20 at the Palais des

RHEA-AI

neutral

04/26/22 4:15 PM

NYSE : EW

EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2022.First Quarter Highlights and OutlookQ1 sales grew 10 percent to $1.34 billion; underlying 1 13 percent Q1 TAVR sales grew 11 percent; underlying

RHEA-AI

positive

04/19/22 7:05 AM

NYSE : EW

conferencesearnings

EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2022 after the market closes on Tuesday, April 26, 2022, and will host a conference call at 5:00 p.m. ET that day to discuss those results.To

RHEA-AI

neutral

03/31/22 9:15 AM

NYSE : EW

fda approval

EDWARDS MITRIS RESILIA VALVE RECEIVES FDA APPROVAL FOR MITRAL REPLACEMENT SURGERIES

Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position.The MITRIS RESILIA

RHEA-AI

very positive

01/26/22 4:15 PM

NYSE : EW

EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2021.Fourth Quarter Highlights and Outlook2021 sales grew 19 percent, or 18 percent on an underlying 1 basis Q4 sales grew 12 percent to $1.33

RHEA-AI

very positive

01/19/22 7:05 AM

NYSE : EW

conferencesearnings

EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 26, 2022

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2021 after the market closes on Wednesday, January 26, 2022, and will host a conference call at 5:00 p.m. ET that day to discuss those

RHEA-AI

neutral

01/05/22 8:10 AM

NYSE : EW

conferences

EDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate at the J.P. Morgan Healthcare Conference on Monday, January 10, 2022.Michael A. Mussallem, chairman and chief executive officer, is scheduled to present virtually at 11:15

RHEA-AI

neutral

12/20/21 9:05 AM

NYSE : EW

fda approval

EDWARDS RECEIVES FDA APPROVAL FOR SAPIEN 3 WITH ALTERRA PRESTENT FOR TRANSCATHETER PULMONIC VALVE REPLACEMENT

Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent (SAPIEN 3 with Alterra) for patients with

RHEA-AI

positive

12/08/21 9:05 AM

NYSE : EW

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance 1 today during its annual investor conference.Highlights of today's

RHEA-AI

neutral